Search Results - "DE LARRANAGA, G. F"

Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics? by Udry, S., Aranda, F. M., Latino, J. O., Larrañaga, G. F.

“…Summary Background In up to 50% of couples affected by recurrent pregnancy loss, no identifiable cause is established. Fetal and maternal factors may be…”
Get full text

Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile by Latino, J O, Udry, S, Aranda, F M, Perés Wingeyer, S D A, Fernández Romero, D S, de Larrañaga, G F

“…Conventional treatment of obstetric antiphospholipid syndrome fails in approximately 20–30% of pregnant women without any clearly identified risk factor. It is…”
Get full text

Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: the first case reported by de Larrañaga, G F, Remondino, G I, Forastiero, R R, Cunto, E R, Narbaitz, M, Olenchuk, A B, Zala, N S, Juan, J A San

“…The case of a man with diagnosis of Kikuchi-Fujimoto disease (KFD) and catastrophic antiphospholipid syndrome (CAPS) is reported. He presented prolonged fever,…”
Get full text

Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?: reply by Udry, S., Aranda, F. M., Latino, J. O., Larrañaga, G. F.

Get full text

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment by DE LARRANAGA, G. F, PERES WINGEYER, S. D. A, PUGA, L. M, ALONSO, B. S, BENETUCCI, J. A

“…Insulin resistance is associated with highly active antiretroviral therapy in HIV-infected patients, and the risk of developing insulin resistance is increased…”
Get full text

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies by Forastiero, R R, Martinuzzo, M E, de Larrañaga, G F

“…The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In…”
Get full text

High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity by de Larrañaga, G F, Forastiero, R R, Martinuzzo, M E, Carreras, L O, Tsariktsian, G, Sturno, M M, Alonso, B S

“…Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates…”
Get full text

Different Types of Antiphospholipid Antibodies in AIDS: A Comparison with Syphilis and the Antiphospholipid Syndrome by de Larrañaga, Gabriela F., Forastiero, Ricardo R., Carreras, Luis O., Alonso, Beatriz S.

“…Alloimmune antiphospholipid antibodies react with phospholipids and are an epiphenomenon of an infectious disease. Most autoimmune antiphospholipid antibodies…”
Get full text

Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies by MARTINUZZO, M. E, DE LARRANAGA, G. F, FORASTIERO, R. R, PELEGRI, Y, FARINA, M. H, ALONSO, B. S, KORDICH, L. C, CARRERAS, L. O

“…To evaluate plasma levels of markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with or without antiphospholipid…”
Get full text

Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients by Wingeyer, Silvia D Perés, Graffigna, Mabel N, Belli, Susana H, Benetucci, Jorge, de Larrañaga, Gabriela F

“…Plasminogen activator inhibitor-1 (PAI-1) and tumor necrosis factor-α (TNF-α) are increased in the circulation of obese persons. Because a direct link between…”
Get more information

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients by de Larrañaga, Gabriela F, Petroni, Alejandro, Deluchi, Gabriel, Alonso, Beatriz S, Benetucci, Jorge A

“…The endothelium participates in haemostasis, inflammation, blood pressure regulation and other physiological systems. Consequently, endothelial dysfunction has…”
Get full text

Endothelial markers and HIV infection in the era of highly active antiretroviral treatment by de Larrañaga, Gabriela F, Bocassi, Andrea R, Puga, Liliana M, Alonso, Beatriz S, Benetucci, Jorge A

“…Many circumstances can induce activation and/or injury of the endothelium that plays a role in the development of vascular complications. Raised plasma levels…”
Get full text

Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases by de Larrañaga, G F, Harris, N, Pierangeli, S S, Alonso, B S, Schroder, T, Fainboim, H

“…Antiphospholipid antibodies (aPL) have been associated with different diseases. They are defined as a large family of immunoglobulins (Ig) of either…”
Get more information

Soluble thrombomodulin levels among women with a history of recurrent pregnancy loss, with or without antiphospholipid antibodies by de Larrañaga, Gabriela F, Remondino, Graciela, Alonso, Beatriz S, Voto, Liliana

“…The endothelial cells produce substances whose elevated plasma levels acquire predictive value for the development of events. For instance, soluble…”
Get full text

Estudio de marcadores de coagulación e inflamación y variantes genéticas de trombofilia al momento de la admisión hospitalaria para predecir mortalidad en una cohorte de la primera ola de COVID-19 en Argentina by Peres, SDA, Aranda, FM, Peralta, M, Cunto, E, Chediack, V, Chamorro, JG, De Larrañaga, GF

“…Introducción: los cuadros clínicos más graves y los desenlaces fatales resultantes de la infección por SARS-CoV-2 han sido asociados con una hiperactivación…”
Get full text